Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122707) titled 'A prospective non-inferiority study of non-invasive 18F-FDG combined with 18F-FES dual-tracer PET-CT in place of sentinel lymph node biopsy for evaluating axillary lymph node status in patients with estrogen receptor-positive breast cancer' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
Patients with estrogen receptor-positive breast cancer
Intervention:
Experimental Group (SLNB Exemption):18F-FDG/18F-FES PET-CT guided exemption of sentinel lymph node biopsy (SLNB)
Recruitment Status: Recruitin...